Clalit Health Services Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04612413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Imaging institute, Haemek Medical Center, Afula, Israel. | Lady Davis Carmel Medical Center | Rabin medical center, Belinson Campus, Petah Tiqwa Isarel

Active Ingredients

Drugs in Phase 2 Trials (1)

allocetra-ots (1 trial)

Drugs in Other Trials (2)

castor oil (1 trial)

date (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pneumonia (Phase 2)

Sepsis (Phase 2)

Toxemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3